264 related articles for article (PubMed ID: 19049658)
1. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
Bouzom F; Walther B
Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy in childhood: what has been done and what has to be done?
Bartels H
Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
[TBL] [Abstract][Full Text] [Related]
3. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drugs in pediatrics using K-PD models: perspectives.
Tod M
Fundam Clin Pharmacol; 2008 Dec; 22(6):589-94. PubMed ID: 19049659
[TBL] [Abstract][Full Text] [Related]
5. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
6. Integration of modelling and simulation into the development of intravenous busulfan in paediatrics: an industrial experience.
Nguyen L
Fundam Clin Pharmacol; 2008 Dec; 22(6):599-604. PubMed ID: 19049661
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic aspects of pediatric drug therapy].
Pokrajac M
Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():22-6. PubMed ID: 18193797
[TBL] [Abstract][Full Text] [Related]
8. Population approaches in paediatrics.
Chatelut E
Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
[TBL] [Abstract][Full Text] [Related]
10. Can positron emission tomography facilitate paediatric drug development?
Zimmer L
Fundam Clin Pharmacol; 2008 Dec; 22(6):595-8. PubMed ID: 19049660
[TBL] [Abstract][Full Text] [Related]
11. Dosing dilemmas in obese children.
Mulla H; Johnson TN
Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-driven approaches for the guidance of first-in-children dosing.
Edginton AN
Paediatr Anaesth; 2011 Mar; 21(3):206-13. PubMed ID: 21129100
[TBL] [Abstract][Full Text] [Related]
13. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants.
Ginsberg G; Hattis D; Sonawane B
Toxicol Appl Pharmacol; 2004 Jul; 198(2):164-83. PubMed ID: 15236952
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
15. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
17. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
Patel P; Mulla H; Tanna S; Pandya H
Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
[TBL] [Abstract][Full Text] [Related]
18. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
19. The problems in scaling adult drug doses to children.
Johnson TN
Arch Dis Child; 2008 Mar; 93(3):207-11. PubMed ID: 17363397
[TBL] [Abstract][Full Text] [Related]
20. The effects of extremes of age on drug action.
Wilson K; Hanson J
Methods Find Exp Clin Pharmacol; 1980 Dec; 2(6):303-12. PubMed ID: 6152996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
